Alerts will be sent to your verified email
Verify EmailSHUKRAPHAR
|
Shukra Pharma
|
Syncom Formulations
|
Venus Remedies
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 9.79 % | 8.87 % |
|
5yr average Equity Multiplier
|
2.02 | 1.41 | 1.32 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.81 | 0.96 |
|
5yr Avg Net Profit Margin
|
13.41 % | 8.78 % | 6.91 % |
|
Price to Book
|
14.76 | 3.54 | 2.32 |
|
P/E
|
60.14 | 19.45 | 18.07 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | 61.57 Days | 46.96 Days |
|
Inventory Days
|
40.87 Days | 27.32 Days | 75.64 Days |
|
Days Receivable
|
186.38 Days | 82.75 Days | 54.28 Days |
|
Days Payable
|
342.97 Days | 79.41 Days | 58.86 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 31.44 | 396.11 |
|
5yr Avg ROCE
|
14.63 % | 13.63 % | 8.42 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 9.97 % | 10.14 % |
|
5 yr average Debt to Equity
|
0.23 | 0.19 | 0.08 |
|
5yr CAGR Net Profit
|
119.04 % | 36.24 % | -6.01 % |
|
5yr Average Return on Assets
|
8.68 % | 7.11 % | 6.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 50.57 % | 41.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shukra Pharma
|
Syncom Formulations
|
Venus Remedies
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|